PE20001593A1 - Aralquilo mono-aciloxi utiles como relajantes musculares - Google Patents

Aralquilo mono-aciloxi utiles como relajantes musculares

Info

Publication number
PE20001593A1
PE20001593A1 PE2000000069A PE0000692000A PE20001593A1 PE 20001593 A1 PE20001593 A1 PE 20001593A1 PE 2000000069 A PE2000000069 A PE 2000000069A PE 0000692000 A PE0000692000 A PE 0000692000A PE 20001593 A1 PE20001593 A1 PE 20001593A1
Authority
PE
Peru
Prior art keywords
bis
dibromide
acetoxybenzyl
alkyl
aralkyl
Prior art date
Application number
PE2000000069A
Other languages
English (en)
Inventor
Lee Chingmuh
Laszlo Gyermek
Young Moon Cho
Original Assignee
Newlaxant Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Newlaxant Llc filed Critical Newlaxant Llc
Publication of PE20001593A1 publication Critical patent/PE20001593A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

SE REFIERE A DERIVADOS DE BIS-AMONIO CUATERNARIO DE ARALQUILO Y ARALQUENILO ACILOXI SUSTITUIDOS DE ESTERES DE AMINOALCANOLES CICLICOS DE ACIDOS DICARBOXILICOS, DE FORMULA a, b; DONDE R1 Y R1` SON ARALQUILO, ARALQUENILO MONOACILOXI SUSTITUIDO; R2 Y R2' SON ALQUILO, ALQUENILO, ALQUINILO; A ES ALCANODICARBONILO, ALQUENODICARBONILO, ENTRE OTROS; n, m Y p SON 0-2; R3 Y R3' SON H, CH3, ALQUILO; R4 Y R4' SON H, CH3, ALQUILO; R3 Y R4 JUNTOS FORMAN CH=CH, (CH2)h-Y-(CH2)k, GRUPO a; Y ES CH2, O, S; h Y k SON 0-3; R3' Y R4' FORMAN JUNTOS (CH2)h-Y-(CH2)k. Y ES CH2, O, S; h, k SON 0-3; R1 Y R1', R2 Y R2' R3 Y R3', R4 Y R4' SON IGUALES Y DIFERENTES; X ES UN ANION FARMACEUTICAMENTE ACEPTABLE. SON COMPUESTOS PREFERIDOS BIS[N-(4-ACETOXIBENCIL)TROPANO-3O-IL]CICLOBUTANO-1,2-DICARBOXILICO DIBROMURO; BIS[N-(3-ACETOXIBENCIL)TROPANO-3O-IL]CICLOBUTANO-1,2-DICARBOXILATO DIBROMURO; BIS[N-(4-ACETOXIBENCIL)GRANATANIO-3-IL]SUCCINATO DIBROMURO, BIS-[N-(4-ACETOXIBENCIL)GRANATANIO-3-IL]GLUTARATO DIBROMURO, ENTRE OTROS. EL COMPUESTO I ES UN BLOQUEADOR MUSCULAR Y PUEDEN SER UTILES COMO RELAJANTES MUSCULARES
PE2000000069A 1999-02-01 2000-01-31 Aralquilo mono-aciloxi utiles como relajantes musculares PE20001593A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11839299P 1999-02-01 1999-02-01

Publications (1)

Publication Number Publication Date
PE20001593A1 true PE20001593A1 (es) 2001-01-16

Family

ID=22378296

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000000069A PE20001593A1 (es) 1999-02-01 2000-01-31 Aralquilo mono-aciloxi utiles como relajantes musculares

Country Status (21)

Country Link
EP (1) EP1150673A4 (es)
JP (1) JP2002535366A (es)
KR (1) KR20010108125A (es)
CN (1) CN1338934A (es)
AR (1) AR022472A1 (es)
AU (1) AU2634900A (es)
BR (1) BR0007863A (es)
CA (1) CA2360790A1 (es)
CO (1) CO5170470A1 (es)
CZ (1) CZ20012780A3 (es)
HK (1) HK1039455A1 (es)
HU (1) HUP0200413A3 (es)
IL (1) IL144249A0 (es)
MX (1) MXPA01007783A (es)
NO (1) NO20013741L (es)
NZ (1) NZ513064A (es)
PE (1) PE20001593A1 (es)
PL (1) PL349099A1 (es)
TR (1) TR200102196T2 (es)
WO (1) WO2000044377A1 (es)
ZA (1) ZA200105882B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0204087D0 (en) * 2002-02-21 2002-04-10 Legislator 1563 Ltd Di-ester derivatives as short acting neuromuscular blockers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2746964A (en) * 1953-11-02 1956-05-22 Lakeside Lab Inc Dicarboxylic acid esters of nu-alkyl-3-hydroxypiperidine and salts thereof
AT292702B (de) * 1968-12-29 1971-09-10 Egyt Gyogyszervegyeszeti Gyar Verfahren zur Herstellung von neuen N-Metyl-piperidin-Derivaten sowie der Säureadditionssalze und der Oniumderivate dieser Verbindungen
US5494898A (en) * 1991-02-13 1996-02-27 Ohmeda Pharmaceutical Products Division Inc. Peptide skeletal muscle relaxants
US5990124A (en) * 1997-10-24 1999-11-23 Gyermek; Laszlo Neuromuscular relaxants

Also Published As

Publication number Publication date
PL349099A1 (en) 2002-07-01
CZ20012780A3 (cs) 2002-01-16
NO20013741D0 (no) 2001-07-31
KR20010108125A (ko) 2001-12-07
HUP0200413A2 (en) 2002-06-29
ZA200105882B (en) 2003-02-18
EP1150673A1 (en) 2001-11-07
AU2634900A (en) 2000-08-18
IL144249A0 (en) 2002-05-23
EP1150673A4 (en) 2002-04-24
CO5170470A1 (es) 2002-06-27
CA2360790A1 (en) 2000-08-03
AR022472A1 (es) 2002-09-04
NO20013741L (no) 2001-09-19
TR200102196T2 (tr) 2002-01-21
WO2000044377A1 (en) 2000-08-03
CN1338934A (zh) 2002-03-06
HK1039455A1 (zh) 2002-04-26
JP2002535366A (ja) 2002-10-22
MXPA01007783A (es) 2002-08-20
BR0007863A (pt) 2001-11-06
HUP0200413A3 (en) 2002-11-28
NZ513064A (en) 2003-08-29

Similar Documents

Publication Publication Date Title
ATE114304T1 (de) Aminoalkylindole, verfahren zu deren herstellung und diese enthaltende pharmazeutische präparate.
EP1245249A3 (fr) Utilisation d'un composé amphipathique cationique comme agent de transfection, comme adjuvant de vaccin, ou comme medicament
KR910020009A (ko) 비사이클릭 1-아자-사이클로알칸
TNSN04208A1 (fr) Derives de n-[phenyl(piperidin-2-yl)methyl] benzamide, leur preparation et leur application en therapeutique
KR900018098A (ko) 피리돈 카르복실산과 항균제
KR880013888A (ko) 신규 디티오아세탈 화합물, 그의 제조방법 및 이 화합물로 되는 제약 조성물
PT85014A (fr) Derives de benzo ]b" thiophene et benzo ]b" furannecarboxamides leurs procedes de preparation et les medicaments les contenant
KR880012227A (ko) 도파민 수용체 길항제의 신규사용법
KR910004633A (ko) 신규한 2-옥소-1옥사-8-아자스피로[4,5]데칸 유도체와 이들을 포함하는 약학적 조성물 및 그 제조방법
IL72166A0 (en) Beta-carboline derivatives and pharmaceutical compositions containing the same
DE69527787D1 (de) Verfahren und zwischenprodukte zur herstellung von piperazinderivaten
ATE110721T1 (de) 2-alkyl-3-benzoylbenzofurane und diese enthaltende pharmazeutische zusammensetzungen.
KR950702978A (ko) 아미드 유도체(Amide derivatives)
IL66835A0 (en) Triazoloquinazolone derivatives and their salts,their preparation,their use as medicaments and the compositions containing them
PE20001593A1 (es) Aralquilo mono-aciloxi utiles como relajantes musculares
KR900016178A (ko) 2-치환 n,n'-디트리메톡시벤조일 피페라진, 그의 제조 방법 및 그를 함유하는 치료 조성물
DE3670630D1 (de) Aminoalkyl-substituierte harnstoffderivate, deren saeureadditionssalze und enantiomere.
DE69315363D1 (de) Amphotere tricyclische Verbindungen als antihistaminische und antiallergische Mittel
KR950032158A (ko) 신규의 티아진 또는 티오모폴린 유도체
JPS5495649A (en) Light stabilizer for synthetic resin
ATE7137T1 (de) Nitrosoureum-derivate, verfahren zu deren herstellung, und diese enthaltende pharmazeutische zusammensetzungen.
FR2549062B1 (fr) Nouveaux derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2639944B1 (fr) Nouveaux derives de l'indole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE3770117D1 (de) Neue 1-/ 3-(2-dialkylaminoaethoxy)-2-thienyl/-3-phenyl-1-propanone und ihre saeureadditionssalze und verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE90087T1 (de) Phenothiazinderivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.

Legal Events

Date Code Title Description
FC Refusal